 | • レポートコード：MRC2-11QY12554 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はループス腎炎のグローバル市場について調査・分析したレポートです。種類別（診断、薬剤）市場規模、用途別（病院、クリニック、外来手術センター、製薬会社）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ループス腎炎の競争状況、市場シェア ・世界のループス腎炎市場：種類別市場規模 2015年-2020年（診断、薬剤） ・世界のループス腎炎市場：種類別市場規模予測 2021年-2026年（診断、薬剤） ・世界のループス腎炎市場：用途別市場規模 2015年-2020年（病院、クリニック、外来手術センター、製薬会社） ・世界のループス腎炎市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来手術センター、製薬会社） ・北米のループス腎炎市場分析：米国、カナダ ・ヨーロッパのループス腎炎市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのループス腎炎市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のループス腎炎市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのループス腎炎市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Merck、Bristol-Myers Squibb、Eli Lilly、GlaxoSmithKline、myVMC ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. While the primary cause of the disease is unknown, it is expected that factors such as viruses, infections, pollutants, and toxic chemicals, along with family history plays a role in causing the disease. The disease is more common in women compared to men.
The growing prevalence of lupus nephritis and awareness among patients have propelled the growth of the global lupus nephritis market. Rise in number of clinical trials conducted by key market players and the launch of new biologic drugs will also augment the growth of the global lupus nephritis market. However, prolonged regulatory processes regarding the approval of biologic drugs are likely to hamper the market’s growth in the near future.
Market Analysis and Insights: Global Lupus Nephritis Market
The global Lupus Nephritis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Lupus Nephritis Scope and Market Size
Lupus Nephritis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lupus Nephritis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Merck
Bristol-Myers Squibb
Eli Lilly
GlaxoSmithKline
myVMC
…
Market segment by Type, the product can be split into
Diagnose
Medications
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Pharmaceutical Companies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lupus Nephritis Revenue
1.4 Market by Type
1.4.1 Global Lupus Nephritis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnose
1.4.3 Medications
1.5 Market by Application
1.5.1 Global Lupus Nephritis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Pharmaceutical Companies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lupus Nephritis Market Perspective (2015-2026)
2.2 Global Lupus Nephritis Growth Trends by Regions
2.2.1 Lupus Nephritis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lupus Nephritis Historic Market Share by Regions (2015-2020)
2.2.3 Lupus Nephritis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lupus Nephritis Market Growth Strategy
2.3.6 Primary Interviews with Key Lupus Nephritis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lupus Nephritis Players by Market Size
3.1.1 Global Top Lupus Nephritis Players by Revenue (2015-2020)
3.1.2 Global Lupus Nephritis Revenue Market Share by Players (2015-2020)
3.1.3 Global Lupus Nephritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lupus Nephritis Market Concentration Ratio
3.2.1 Global Lupus Nephritis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lupus Nephritis Revenue in 2019
3.3 Lupus Nephritis Key Players Head office and Area Served
3.4 Key Players Lupus Nephritis Product Solution and Service
3.5 Date of Enter into Lupus Nephritis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lupus Nephritis Historic Market Size by Type (2015-2020)
4.2 Global Lupus Nephritis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lupus Nephritis Market Size by Application (2015-2020)
5.2 Global Lupus Nephritis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lupus Nephritis Market Size (2015-2020)
6.2 Lupus Nephritis Key Players in North America (2019-2020)
6.3 North America Lupus Nephritis Market Size by Type (2015-2020)
6.4 North America Lupus Nephritis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lupus Nephritis Market Size (2015-2020)
7.2 Lupus Nephritis Key Players in Europe (2019-2020)
7.3 Europe Lupus Nephritis Market Size by Type (2015-2020)
7.4 Europe Lupus Nephritis Market Size by Application (2015-2020)
8 China
8.1 China Lupus Nephritis Market Size (2015-2020)
8.2 Lupus Nephritis Key Players in China (2019-2020)
8.3 China Lupus Nephritis Market Size by Type (2015-2020)
8.4 China Lupus Nephritis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lupus Nephritis Market Size (2015-2020)
9.2 Lupus Nephritis Key Players in Japan (2019-2020)
9.3 Japan Lupus Nephritis Market Size by Type (2015-2020)
9.4 Japan Lupus Nephritis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lupus Nephritis Market Size (2015-2020)
10.2 Lupus Nephritis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lupus Nephritis Market Size by Type (2015-2020)
10.4 Southeast Asia Lupus Nephritis Market Size by Application (2015-2020)
11 India
11.1 India Lupus Nephritis Market Size (2015-2020)
11.2 Lupus Nephritis Key Players in India (2019-2020)
11.3 India Lupus Nephritis Market Size by Type (2015-2020)
11.4 India Lupus Nephritis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lupus Nephritis Market Size (2015-2020)
12.2 Lupus Nephritis Key Players in Central & South America (2019-2020)
12.3 Central & South America Lupus Nephritis Market Size by Type (2015-2020)
12.4 Central & South America Lupus Nephritis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Lupus Nephritis Introduction
13.1.4 Roche Revenue in Lupus Nephritis Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Lupus Nephritis Introduction
13.2.4 Merck Revenue in Lupus Nephritis Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb Lupus Nephritis Introduction
13.3.4 Bristol-Myers Squibb Revenue in Lupus Nephritis Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Lupus Nephritis Introduction
13.4.4 Eli Lilly Revenue in Lupus Nephritis Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Lupus Nephritis Introduction
13.5.4 GlaxoSmithKline Revenue in Lupus Nephritis Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 myVMC
13.6.1 myVMC Company Details
13.6.2 myVMC Business Overview
13.6.3 myVMC Lupus Nephritis Introduction
13.6.4 myVMC Revenue in Lupus Nephritis Business (2015-2020)
13.6.5 myVMC Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Lupus Nephritis Key Market Segments
Table 2. Key Players Covered: Ranking by Lupus Nephritis Revenue
Table 3. Ranking of Global Top Lupus Nephritis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lupus Nephritis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnose
Table 6. Key Players of Medications
Table 7. Global Lupus Nephritis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Lupus Nephritis Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Lupus Nephritis Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Lupus Nephritis Market Share by Regions (2015-2020)
Table 11. Global Lupus Nephritis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Lupus Nephritis Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Lupus Nephritis Market Growth Strategy
Table 17. Main Points Interviewed from Key Lupus Nephritis Players
Table 18. Global Lupus Nephritis Revenue by Players (2015-2020) (Million US$)
Table 19. Global Lupus Nephritis Market Share by Players (2015-2020)
Table 20. Global Top Lupus Nephritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lupus Nephritis as of 2019)
Table 21. Global Lupus Nephritis by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Lupus Nephritis Product Solution and Service
Table 24. Date of Enter into Lupus Nephritis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Lupus Nephritis Market Size by Type (2015-2020) (Million US$)
Table 27. Global Lupus Nephritis Market Size Share by Type (2015-2020)
Table 28. Global Lupus Nephritis Revenue Market Share by Type (2021-2026)
Table 29. Global Lupus Nephritis Market Size Share by Application (2015-2020)
Table 30. Global Lupus Nephritis Market Size by Application (2015-2020) (Million US$)
Table 31. Global Lupus Nephritis Market Size Share by Application (2021-2026)
Table 32. North America Key Players Lupus Nephritis Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Lupus Nephritis Market Share (2019-2020)
Table 34. North America Lupus Nephritis Market Size by Type (2015-2020) (Million US$)
Table 35. North America Lupus Nephritis Market Share by Type (2015-2020)
Table 36. North America Lupus Nephritis Market Size by Application (2015-2020) (Million US$)
Table 37. North America Lupus Nephritis Market Share by Application (2015-2020)
Table 38. Europe Key Players Lupus Nephritis Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Lupus Nephritis Market Share (2019-2020)
Table 40. Europe Lupus Nephritis Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Lupus Nephritis Market Share by Type (2015-2020)
Table 42. Europe Lupus Nephritis Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Lupus Nephritis Market Share by Application (2015-2020)
Table 44. China Key Players Lupus Nephritis Revenue (2019-2020) (Million US$)
Table 45. China Key Players Lupus Nephritis Market Share (2019-2020)
Table 46. China Lupus Nephritis Market Size by Type (2015-2020) (Million US$)
Table 47. China Lupus Nephritis Market Share by Type (2015-2020)
Table 48. China Lupus Nephritis Market Size by Application (2015-2020) (Million US$)
Table 49. China Lupus Nephritis Market Share by Application (2015-2020)
Table 50. Japan Key Players Lupus Nephritis Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Lupus Nephritis Market Share (2019-2020)
Table 52. Japan Lupus Nephritis Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Lupus Nephritis Market Share by Type (2015-2020)
Table 54. Japan Lupus Nephritis Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Lupus Nephritis Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Lupus Nephritis Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Lupus Nephritis Market Share (2019-2020)
Table 58. Southeast Asia Lupus Nephritis Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Lupus Nephritis Market Share by Type (2015-2020)
Table 60. Southeast Asia Lupus Nephritis Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Lupus Nephritis Market Share by Application (2015-2020)
Table 62. India Key Players Lupus Nephritis Revenue (2019-2020) (Million US$)
Table 63. India Key Players Lupus Nephritis Market Share (2019-2020)
Table 64. India Lupus Nephritis Market Size by Type (2015-2020) (Million US$)
Table 65. India Lupus Nephritis Market Share by Type (2015-2020)
Table 66. India Lupus Nephritis Market Size by Application (2015-2020) (Million US$)
Table 67. India Lupus Nephritis Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Lupus Nephritis Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Lupus Nephritis Market Share (2019-2020)
Table 70. Central & South America Lupus Nephritis Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Lupus Nephritis Market Share by Type (2015-2020)
Table 72. Central & South America Lupus Nephritis Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Lupus Nephritis Market Share by Application (2015-2020)
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche Product
Table 77. Roche Revenue in Lupus Nephritis Business (2015-2020) (Million US$)
Table 78. Roche Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Product
Table 82. Merck Revenue in Lupus Nephritis Business (2015-2020) (Million US$)
Table 83. Merck Recent Development
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Product
Table 87. Bristol-Myers Squibb Revenue in Lupus Nephritis Business (2015-2020) (Million US$)
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Eli Lilly Company Details
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Product
Table 92. Eli Lilly Revenue in Lupus Nephritis Business (2015-2020) (Million US$)
Table 93. Eli Lilly Recent Development
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Product
Table 97. GlaxoSmithKline Revenue in Lupus Nephritis Business (2015-2020) (Million US$)
Table 98. GlaxoSmithKline Recent Development
Table 99. myVMC Company Details
Table 100. myVMC Business Overview
Table 101. myVMC Product
Table 102. myVMC Revenue in Lupus Nephritis Business (2015-2020) (Million US$)
Table 103. myVMC Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lupus Nephritis Market Share by Type: 2020 VS 2026
Figure 2. Diagnose Features
Figure 3. Medications Features
Figure 4. Global Lupus Nephritis Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Lupus Nephritis Report Years Considered
Figure 10. Global Lupus Nephritis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Lupus Nephritis Market Share by Regions: 2020 VS 2026
Figure 12. Global Lupus Nephritis Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Lupus Nephritis Market Share by Players in 2019
Figure 15. Global Top Lupus Nephritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lupus Nephritis as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Lupus Nephritis Revenue in 2019
Figure 17. North America Lupus Nephritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Lupus Nephritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Lupus Nephritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Lupus Nephritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Lupus Nephritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Lupus Nephritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Lupus Nephritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
ループス治療の世界市場（～2026年） Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition. According to the report, one of the major drivers for this market is high prevalence rate. Market Analysis and Insights: Global Lupus Therapeutic Market The global Lupus Therapeutic market size …- 全身性エリテマトーデス（SLE）治療薬の世界市場（～2026年） SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces …
- 外来手術センターの世界市場（～2026年） Market Analysis and Insights: Global Ambulatory Surgical Centres Market The global Ambulatory Surgical Centres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ambulatory Surgical Centres Scope and Market Size Ambulator…
- 非受容体型チロシンプロテインキナーゼTYK2の世界市場（～2026年） Market Analysis and Insights: Global Non Receptor Tyrosine Protein Kinase TYK2 Market The global Non Receptor Tyrosine Protein Kinase TYK2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Non Receptor Tyrosine Protein K…
- Tリンパ球活性化抗原CD86の世界市場（～2026年） Market Analysis and Insights: Global T Lymphocyte Activation Antigen CD86 Market The global T Lymphocyte Activation Antigen CD86 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Lymphocyte Activation Antigen CD86 Scop…